Records containing: Malignant Brain Tumor
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-12-17NeuroPathways: An Information and Support Intervention for Patients With Malignant Brain Tumors
-
CLINICAL_TRIALS study record update · 2025-12-15A Prospective, Multi-centered, Assessor-blinded Clinical Performance Study to Evaluate the Sensitivity and Specificity of the cCeLL-Ex Vivo Device for Intraoperative Brain Tumor Diagnosis.
-
CLINICAL_TRIALS study record update · 2025-12-03Evaluation of the Contribution of NODDI Protocol Tractography in Brain Tumor Surgery
-
CLINICAL_TRIALS study record update · 2025-11-20Phase I Trial Assessing the Safety of the Repeated Ultrasound-induced Opening of the Blood-brain Barrier in Pediatric Patients With Refractory Supra-tentorial Malignant Brain Tumors Before Chemotherapy Administration
-
CLINICAL_TRIALS study record update · 2025-07-16Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-07-14An ACT-Based Supportive Intervention for Patients With Central Nervous System Tumors
-
CLINICAL_TRIALS study record update · 2025-07-09A Phase 1 Study of Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors
-
CLINICAL_TRIALS study record update · 2024-12-05NeuroCARE: Psychological Intervention for Caregivers of Patients With Malignant Gliomas (RCT)
-
CLINICAL_TRIALS study record update · 2024-03-27A Phase I/II Study of the Combination of Indoximod and Temozolomide for Adult Patients With Temozolomide-Refractory Primary Malignant Brain Tumors
-
CLINICAL_TRIALS study record update · 2022-10-18Comparison of Rates DMBT1 ( Glycoprotein) in Sputum of CF Patients Colonized Patients Between Chronic and Non-chronic Patients Colonized With Pseudomonas Aeruginosa
-
CLINICAL_TRIALS study record update · 2022-08-15Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children
-
CLINICAL_TRIALS study record update · 2021-09-08Retrospective, Multi-center Cross-sectional Study on Paediatric Central Nervous Systerm Tumours by CNOG-MC001 Collaborative Group
-
CLINICAL_TRIALS study record update · 2021-07-15A Phase II, Multi-center, Open-label Study of a Conditionally Replicative Adenovirus (DNX-2401) With Pembrolizumab (KEYTRUDA®) for Recurrent Glioblastoma or Gliosarcoma (CAPTIVE/KEYNOTE-192)
-
CLINICAL_TRIALS study record update · 2020-06-04A Phase I Trial of Indoximod and Temozolomide-Based Therapy for Children With Progressive Primary Brain Tumors
-
CLINICAL_TRIALS study record update · 2015-02-18A Computer-Based Intervention for Distance Caregivers of Parents With Advanced Cancer
-
CLINICAL_TRIALS study record update · 2009-08-07Phase I Studies of TarcevaTM (Erlotinib Hydrochloride, OSI-774) as Single Agent in Children With Refractory and Relapsed Malignant Brain Tumors and in Combination With Irradiation in Newly Diagnosed Brain Stem Glioma